U.S. Residents Only, 18 Years and Older.
HOME
|
CONTACT US
|
INDEX
BMS.com-US
Study Connect Home
About Clinical Studies
What is a clinical study?
Who can participate?
Are there any risks to participants?
What investigational drug names are used in clinical study listings
Understanding clinical study phases
What is Informed Consent?
How are participants protected?
Clinical Study Insights
Pediatric Clinical Studies
Why are pediatric clinical studies important?
Video Gallery: What people are saying
Informed consent in pediatric studies
Caregivers
Some considerations for caregivers of study participants
Informed consent for caregivers
Caregiver resources
Clinical Study FAQs
Study ID (Protocol Number)
AI452-016
STUDY LOCATIONS*
Alamo Medical Research
San Antonio, TX 78215
Recruiting
Henry Ford Health System
Detroit, MI 48202
Recruiting
Duke University Medical Center
Durham, NC 27710
Recruiting
Mayo Clinic
Rochester, MN 55905
Recruiting
*Not all study site locations may be listed - please check back soon for updated
information. For more information regarding other participating countries, please
visit
clinicaltrials.gov
.
STUDY NAME
Three-year Follow-up Study of
Subjects
Who Participated in a Previous Lambda (BMS-914143)
Chronic
Hepatitis C
Clinical Trial
STUDY OVERVIEW
The primary purpose of this study is to determine whether the
hepatitis C
virus
continues to remain unable to be detected in
subjects
who were previously treated with BMS-914143 and achieved
sustained virologic response
The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit
ClinicalTrials.gov
for complete information about this and other clinical studies.